Chief Investigator: Professor Dame Lesley Fallowfield
Data Manager: Shirley May
Funded by: Breast Cancer Research Foundation
Recurrence scores from gene expression profiling tests are used increasingly to determine the likely benefit of adjuvant chemotherapy in early stage breast cancer. Discussions with anxious patients about risk and uncertainty and the rationale for different treatment recommendations can be complex and confusing. The TARGET research programme aims to assist clinicians with these conversations.